SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about change in name of RTA

04 Jan 2025 Evaluate

Pursuant to the regulation 30 of the SEBI Listing Regulations, Medicamen Biotech has informed that the Company has been informed by the RTA that they have changed their name from Link Intime India to MUFG Intime India with effect from December 31, 2024. The company has informed to take note of the same and update the name as ‘MUFG Intime India’ as the RTA of the Company, in the records. The address and other contact details of the RTA of the Company remain unchanged. The Certificate of Incorporation reflecting the name change of the RTA, as received from the RTA, is enclosed.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

258.50 10.00 (4.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×